Nehal Chopra Ratan Capital Management
Nehal Chopra is the founder of Ratan Capital Management, a concentrated investment firm whose public portfolio is followed for high-conviction equity ideas. The firm’s filings often show a focused set of positions rather than a broad index-like book. Investors track Ratan as an example of a smaller, research-driven manager with differentiated stock selection.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$63.7M |
| 2 |
Trip.com Group
TCOM
|
+$29.7M |
| 3 |
Post Holdings
POST
|
+$1.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PF
Pinnacle Foods, Inc.
PF
|
+$41.9M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$39M |
| 3 |
Coty
COTY
|
+$36.3M |
| 4 |
Bausch Health
BHC
|
+$35.7M |
| 5 |
Liberty Global Class A
LBTYA
|
+$3.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.79% |
| 2 | Consumer Staples | 24.91% |
| 3 | Communication Services | 22.31% |
| 4 | Consumer Discretionary | 6.65% |
| 5 | Financials | 2.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $126M | 27.79% |
402,486
+213,942
| +113% | +$63.7M |
|
|
2
Post Holdings
POST
$3.65B
| $81.4M | 17.97% |
2,014,839
+45,852
| +2% | +$1.9M |
|
3
Charter Communications
CHTR
$17.9B
| $62.5M | 13.82% |
341,600
| – | – |
|
|
4
Liberty Global Class A
LBTYA
$3.63B
| $38.4M | 8.49% |
1,039,930
-105,575
| -9% | -$3.99M |
|
|
5
CALL
Bausch Health
BHC
$2.41B
| $30.5M | 6.74% |
+300,000
| New | +$33.7M |
|
|
6
Trip.com Group
TCOM
$29B
| $30.1M | 6.65% |
+650,000
| New | +$29.7M |
|
|
7
Coty
COTY
$2.41B
| $26M | 5.74% |
1,014,495
-1,305,538
| -56% | -$36.3M |
|
8
PUT
CarMax
KMX
$8.82B
| $16.2M | 3.58% |
+300,000
| New | +$17.1M |
|
|
9
CALL
CarMax
KMX
$8.82B
| $14M | 3.1% |
+259,800
| New | +$14.8M |
|
10
Hilltop Holdings
HTH
$2.22B
| $11.5M | 2.53% |
596,884
| – | – |
|
|
HZNP
11
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $10.8M | 2.39% |
500,000
| – | – |
|
12
Kraft Heinz
KHC
$30.3B
| $5.4M | 1.19% |
74,240
| – | – |
|
|
13
Bausch Health
BHC
$2.41B
| – | – |
-317,561
| Closed | -$35.7M |
|
|
ENDP
14
DELISTED
Endo International plc
ENDP
| – | – |
-562,699
| Closed | -$39M |
|
|
PF
15
DELISTED
Pinnacle Foods, Inc.
PF
| – | – |
-999,330
| Closed | -$41.9M |
|
Similar funds
Nehal Chopra's Q4 2015 Portfolio in Review
As of Q4 2015, Nehal Chopra held 15 positions worth $453M, down 1.1% from $458M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Nehal Chopra's Q4 2015 filing shows 4 new, 2 increased, 2 reduced and 3 closed positions. Its largest new stake was Trip.com Group: 650,000 shares worth $30.1M. The largest sale was Pinnacle Foods, Inc., an estimated $41.9M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Consumer Staples and Communication Services.
- Nehal Chopra's largest Q4 2015 buy was Trip.com Group: 650,000 shares worth $30.1M.
- Nehal Chopra added most to Allergan plc in Q4 2015, an estimated $63.7M increase.
- Nehal Chopra's biggest Q4 2015 reduction was Coty, cutting an estimated $36.3M.
- Nehal Chopra fully exited Pinnacle Foods, Inc. in Q4 2015, selling an estimated $41.9M.
- Nehal Chopra's ten largest holdings make up 96% of its $453M portfolio in Q4 2015.
- Nehal Chopra opened 4 new positions and closed 3 in Q4 2015.
- Nehal Chopra's portfolio value fell 1.1% quarter-over-quarter to $453M.
Based on Ratan Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.